期刊文献+

人免疫缺陷病毒II型gag基因在毕赤酵母中表达条件的研究 被引量:4

Study on the Expression Conditions of HIV-2 gag Gene in Pichia pastoris
在线阅读 下载PDF
导出
摘要 目的 :提高人免疫缺陷病毒 II型 ( HIV- 2 ROD) gag基因在毕赤酵母中的表达量。方法 :研究了转化子生长的培养条件 ,包括不同的甲醇诱导浓度、诱导时间、溶解氧、摇瓶转速及不同 p H值对人 HIV- 2 gag表达的影响。表达产物进一步通过盐析和 Sephadex G- 1 0 0分子筛层析柱层析分离纯化。结果 :最佳表达条件是 1 .0 %甲醇诱导 ,诱导时间 3d,大于 85 %的溶解氧 ,摇瓶转速2 5 0 r·min-1,p H6.0~ 6.5 ,目的蛋白表达量达到 2 1 mg· L-1。同时 ,经纯化后得到了纯度大于95 %的目的蛋白。结论 :获得了 HIV- 2 RODgag重组蛋白在巴斯德毕赤酵母系统中分泌表达的最佳表达条件。 Objective:To enhance the expression level of HIV 2 gag gene in Pichia pastoris. Methods:The transformant growth conditions in shake flasks including methanol concentration, induction time, aeration, rotation speeds and pH were optimized. Expressed gag was isolated and purified by sating out and Sephadex G 50 chromatography. Results:More than 85% aeration,3 days for induction, the initial pH of 6.0~6.5, the final methanol concentration of 1.0% and agitation speed of 250 r·min -1 was the optimum inductive condition for gag expression.With this condition, the expressed gag was secreted into fermentation broth and reached a yield approximately 21 mg·L -1 . Conclusion:The optimum inductive condition for gag expression in methanol trophic yeast expression system had been obtained.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2003年第2期135-137,共3页 Journal of Jilin University:Medicine Edition
基金 国家 8 6 3高技术计划项目 (2 0 0 1AA2 15 0 31) 国家杰出青年基金资助课题 (3982 5 119)
关键词 HIV-2 基因 GAG 毕赤酵母 基因表达 HIV 2 Genes,gag Pichia pastoris Gene expression
  • 相关文献

参考文献1

  • 1Sambrook j Fritsch EF.分子克隆实验指南(第2版)[M].北京:科学出版社,1992..

共引文献24

同被引文献39

  • 1张兴群,王梁华,焦炳华,袁勤生.重组人OCIF结构域D1~D6基因在毕赤酵母中的表达[J].分子科学学报,2004,20(4):11-18. 被引量:3
  • 2李再新,罗惠波,周键,左勇,刘达玉.人α-防御素基因克隆及其毕赤酵母表达的研究[J].分子科学学报,2006,22(4):259-263. 被引量:1
  • 3Doan LX,Li M,Chen C,et al. vaccines[ J]. Rev Med Virol, Virus-like particles as HIV-1 2005,15(2) :75.
  • 4McBurney SP,Young KR, Ross TM. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes [ J ]. Virology, 2007,358 ( 2 ) : 334.
  • 5Buonaguro L, Racioppi L, Tornesello ML, et al. Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-I isolate of clade A[J]. Antiviral Res, 2002,54(3) :189.
  • 6Peng S, Frazer IH, Fernando GJ,et al. Papillomavirus virus-hke particles can deliver defined CTL epitopes to the MHC class I pathway[ J]. Virology, 1998,240( 1 ) : 147.
  • 7Cosma A, Nagaraj R, Staib C, et al. Evaluation of modified vaccinia virus Ankara as an alternative vaccine against small- pox in chronically HIV type 1-infected individuals undergoing HAART[J]. AIDS Res Hum Retroviruses,2007,23(6):782.
  • 8Mcfarland E J, Johnson DC, Muresan P, et al. HIV-I vaccine induced immune responses in newborns of HIV-1 infected mothers[ J]. AIDS,2006,20(11) :1 481.
  • 9Kelleher AD, Puls RL, Bebbington M, et al. A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1 [J]. AIDS,2006,20(2): 294.
  • 10Donnelly JJ, Ulmer JB, Liu MA. DNA vaccines [J].Life Sci, 1997, 60 (3): 163 - 172.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部